| |
High BP
|
Dysglycemia
|
Low HDL-C
|
High TG
|
MetS
|
|---|
|
AUC
|
95% CI
|
AUC
|
95% CI
|
AUC
|
95% CI
|
AUC
|
95% CI
|
AUC
|
95% CI
|
|---|
|
Male
|
|
WHtR
|
0.602*
|
0.574–0.630
|
0.669*
|
0.641–0.695
|
0.579*
|
0.543–0.616
|
0.633*
|
0.605–0.660
|
0.739*
|
0.691–0.787
|
|
BRI
|
0.602*
|
0.574–0.630
|
0.669*
|
0.641–0.695
|
0.579*
|
0.543–0.616
|
0.633*
|
0.605–0.660
|
0.739*
|
0.691–0.787
|
|
WWI
|
0.581*
|
0.552–0.609
|
0.655*
|
0.627–0.682
|
0.563*
|
0.527–0.599
|
0.598*
|
0.565–0.632
|
0.689*
|
0.636–0.742
|
|
AVI
|
0.571*
|
0.543–0.599
|
0.617*
|
0.589–0.644
|
0.591*
|
0.555–0.628
|
0.634*
|
0.606–0.666
|
0.743*
|
0.690–0.796
|
|
ABSI
|
0.540#
|
0.512–0.569
|
0.608*
|
0.580–0.665
|
0.561#
|
0.525–0.598
|
0.579*
|
0.550–0.607
|
0.663*
|
0.606–0.719
|
|
Female
|
|
WHtR
|
0.688*
|
0.666–0.710
|
0.713*
|
0.691–0.734
|
0.605*
|
0.581–0.628
|
0.712*
|
0.690–0.733
|
0.817*
|
0.798–0.835
|
|
BRI
|
0.688*
|
0.666–0.710
|
0.713*
|
0.691–0.734
|
0.605*
|
0.581–0.628
|
0.712*
|
0.690–0.733
|
0.817*
|
0.798–0.835
|
|
WWI
|
0.688*
|
0.665–0.710
|
0.705*
|
0.682–0.726
|
0.556*
|
0.532–0.580
|
0.684*
|
0.661–0.706
|
0.768*
|
0.748–0.788
|
|
AVI
|
0.659*
|
0.636–0.682
|
0.692*
|
0.669–0.713
|
0.614*
|
0.590–0.637
|
0.690*
|
0.667–0.712
|
0.819*
|
0.800–0.837
|
|
ABSI
|
0.660*
|
0.637–0.682
|
0.682*
|
0.660–0.704
|
0.541^
|
0.484–0.598
|
0.647*
|
0.623–0.669
|
0.744*
|
0.723–0.765
|
- Bold indicates the maximum
- WtHR waist-to-height ratio, BRI body roundness index, WWI weight adjusted waist index, AVI abdominal volume index, ABSI a body shape index, BP blood pressure, TG triglyceride, HDL-C HDL cholesterol, MetS metabolic syndrome
- *p < 0.001; #p < 0.05; ^p > 0.05
